Literature DB >> 16162816

TRAF7 sequesters c-Myb to the cytoplasm by stimulating its sumoylation.

Yutaka Morita1, Chie Kanei-Ishii, Teruaki Nomura, Shunsuke Ishii.   

Abstract

Small ubiquitin-related modifiers (SUMOs) are proteins that are posttranslationally conjugated to diverse proteins. The c-myb proto-oncogene product (c-Myb) regulates proliferation and differentiation of hematopoietic cells. PIASy is the only known SUMO E3 ligase for c-Myb. Here, we report that TRAF7 binds to c-Myb and stimulates its sumoylation. TRAF7 bound to the DNA-binding domain of c-Myb via its WD40 repeats. TRAF7 has an E3 ubiquitin ligase activity for self-ubiquitination, but TRAF7 also stimulated the sumoylation of c-Myb at Lys-523 and Lys-499, which are the same sites as those used for PIASy-induced sumoylation. TRAF7 inhibited trans-activation induced by wild-type c-Myb, but not by the sumoylation site mutant of c-Myb. The expression of both c-myb and TRAF7 was down-regulated during differentiation of M1 cells. Endogenous TRAF7 localized to both the cytoplasm and nucleus of M1 cells. Consistent with this, significant amounts of sumoylated c-Myb were found in the cytoplasm of M1 cells, whereas nonsumoylated c-Myb was found predominantly in the nucleus. Overexpressed TRAF7 was localized in the cytoplasm of CV-1 cells, and sequestered c-Myb and SUMO1 in the cytosol, whereas PIASy was localized in the nucleus. Thus, TRAF7 negatively regulates c-Myb activity by sequestering c-Myb to the cytosol via sumoylation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16162816      PMCID: PMC1266438          DOI: 10.1091/mbc.e05-08-0731

Source DB:  PubMed          Journal:  Mol Biol Cell        ISSN: 1059-1524            Impact factor:   4.138


  59 in total

1.  Transcriptional activation by the v-myb oncogene and its cellular progenitor, c-myb.

Authors:  K Weston; J M Bishop
Journal:  Cell       Date:  1989-07-14       Impact factor: 41.582

2.  The v-myb oncogene product binds to and activates the promyelocyte-specific mim-1 gene.

Authors:  S A Ness; A Marknell; T Graf
Journal:  Cell       Date:  1989-12-22       Impact factor: 41.582

3.  Transcriptional activation of the c-myc gene by the c-myb and B-myb gene products.

Authors:  H Nakagoshi; C Kanei-Ishii; T Sawazaki; G Mizuguchi; S Ishii
Journal:  Oncogene       Date:  1992-06       Impact factor: 9.867

4.  A putative second cell-derived oncogene of the avian leukaemia retrovirus E26.

Authors:  D Leprince; A Gegonne; J Coll; C de Taisne; A Schneeberger; C Lagrou; D Stehelin
Journal:  Nature       Date:  1983 Nov 24-30       Impact factor: 49.962

5.  Transactivation and transformation by Myb are negatively regulated by a leucine-zipper structure.

Authors:  C Kanei-Ishii; E M MacMillan; T Nomura; A Sarai; R G Ramsay; S Aimoto; S Ishii; T J Gonda
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-01       Impact factor: 11.205

6.  A functional c-myb gene is required for normal murine fetal hepatic hematopoiesis.

Authors:  M L Mucenski; K McLain; A B Kier; S H Swerdlow; C M Schreiner; T A Miller; D W Pietryga; W J Scott; S S Potter
Journal:  Cell       Date:  1991-05-17       Impact factor: 41.582

7.  Delineation of three functional domains of the transcriptional activator encoded by the c-myb protooncogene.

Authors:  H Sakura; C Kanei-Ishii; T Nagase; H Nakagoshi; T J Gonda; S Ishii
Journal:  Proc Natl Acad Sci U S A       Date:  1989-08       Impact factor: 11.205

8.  Transformation by carboxyl-deleted Myb reflects increased transactivating capacity and disruption of a negative regulatory domain.

Authors:  Y L Hu; R G Ramsay; C Kanei-Ishii; S Ishii; T J Gonda
Journal:  Oncogene       Date:  1991-09       Impact factor: 9.867

9.  Carboxy-terminal elements of c-Myb negatively regulate transcriptional activation in cis and in trans.

Authors:  J W Dubendorff; L J Whittaker; J T Eltman; J S Lipsick
Journal:  Genes Dev       Date:  1992-12       Impact factor: 11.361

10.  Expression of myb, myc and fos proto-oncogenes during the differentiation of a murine myeloid leukaemia.

Authors:  T J Gonda; D Metcalf
Journal:  Nature       Date:  1984 Jul 19-25       Impact factor: 49.962

View more
  21 in total

1.  TRAF7 protein promotes Lys-29-linked polyubiquitination of IkappaB kinase (IKKgamma)/NF-kappaB essential modulator (NEMO) and p65/RelA protein and represses NF-kappaB activation.

Authors:  Tiziana Zotti; Antonio Uva; Angela Ferravante; Mariangela Vessichelli; Ivan Scudiero; Michele Ceccarelli; Pasquale Vito; Romania Stilo
Journal:  J Biol Chem       Date:  2011-04-25       Impact factor: 5.157

Review 2.  Cardiac function and disease: emerging role of small ubiquitin-related modifier.

Authors:  Jun Wang
Journal:  Wiley Interdiscip Rev Syst Biol Med       Date:  2010-12-31

Review 3.  Viral manipulation of cellular protein conjugation pathways: The SUMO lesson.

Authors:  Domenico Mattoscio; Chiara V Segré; Susanna Chiocca
Journal:  World J Virol       Date:  2013-05-12

Review 4.  Protein sumoylation in brain development, neuronal morphology and spinogenesis.

Authors:  Carole Gwizdek; Frédéric Cassé; Stéphane Martin
Journal:  Neuromolecular Med       Date:  2013-08-02       Impact factor: 3.843

5.  Fbxw7 acts as an E3 ubiquitin ligase that targets c-Myb for nemo-like kinase (NLK)-induced degradation.

Authors:  Chie Kanei-Ishii; Teruaki Nomura; Tsuyoshi Takagi; Nobumoto Watanabe; Keiichi I Nakayama; Shunsuke Ishii
Journal:  J Biol Chem       Date:  2008-09-02       Impact factor: 5.157

6.  Chromatin Association of Gcn4 Is Limited by Post-translational Modifications Triggered by its DNA-Binding in Saccharomyces cerevisiae.

Authors:  Akhi Akhter; Emanuel Rosonina
Journal:  Genetics       Date:  2016-10-21       Impact factor: 4.562

Review 7.  Sumoylation and regulation of cardiac gene expression.

Authors:  Jun Wang; Robert J Schwartz
Journal:  Circ Res       Date:  2010-07-09       Impact factor: 17.367

8.  SUMOylation of DLX3 by SUMO1 promotes its transcriptional activity.

Authors:  Olivier Duverger; Susie X Chen; Delia Lee; Tianwei Li; P Boon Chock; Maria I Morasso
Journal:  J Cell Biochem       Date:  2011-02       Impact factor: 4.429

9.  A Proteomic Approach to Identify Alterations in the Small Ubiquitin-like Modifier (SUMO) Network during Controlled Mechanical Ventilation in Rat Diaphragm Muscle.

Authors:  Arvind Venkat Namuduri; Gabriel Heras; Jia Mi; Nicola Cacciani; Katarina Hörnaeus; Anne Konzer; Sara Bergström Lind; Lars Larsson; Stefano Gastaldello
Journal:  Mol Cell Proteomics       Date:  2017-04-03       Impact factor: 5.911

10.  UHRF2, a ubiquitin E3 ligase, acts as a small ubiquitin-like modifier E3 ligase for zinc finger protein 131.

Authors:  Yohan Oh; Kwang Chul Chung
Journal:  J Biol Chem       Date:  2013-02-12       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.